Carbohydrate antigen 549 in metastatic breast cancer during cytostatic treatment and follow-up
Authors:
- 31 May 1992
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 28 (4-5) , 845-850
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Epirubicin or epirubicin and vindesine in advanced breast cancer. A Phase III studyAnnals of Oncology, 1990
- Tumor marker kinetics in the monitoring of breast cancerCancer, 1990
- Interpreting laboratory results.BMJ, 1989
- CA‐549: A new tumor marker for patients with advanced breast cancerJournal of Clinical Laboratory Analysis, 1988
- Correlation of serum levels of CA‐549 to disease status in posttreatment serial samples from breast cancer patientsJournal of Clinical Laboratory Analysis, 1988
- Practical Guide to Immunoassay Method Evaluation1987
- The clinical significance of the pattern of elevated serum carcinoembryonic antigen (CEA) levels in recurrent colorectal cancerBritish Journal of Surgery, 1980
- Sequential Carcinoembryonic Antigen Levels in the Therapy of Metastatic Breast CancerAnnals of Internal Medicine, 1978